sars-cov-2

Health and Research - COVID-19

Advisory on Long-COVID and Impact on Cognitive Function in Adults with Intellectual Disability

The purpose of this advisory is to provide background information on newly recognized cognitive impairments,…

Capetivate capetivateNovember 8, 2022

Resources for Professionals

Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome

Studies suggest human trisomy 21 impacts several diseases in an age-dependent manner. Thus, understanding the…

Rigsby RigsbyApril 29, 2022

Resources for Professionals

Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome

The aim of this study was to evaluate the safety and immunogenicity of the BNT162b2…

Rigsby RigsbyMarch 30, 2022

Resources for Professionals

COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

Adults with Down syndrome (DS) are at higher risk for severe outcomes of coronavirus disease…

Rigsby RigsbyMarch 29, 2022

Resources for Professionals

Risk Prediction of COVID-19 Related Death and Hospital Admission in Adults after Vaccination

Objectives: To derive and validate risk prediction algorithms to estimate the risk of COVID-19 related…

Rigsby RigsbyMarch 17, 2022

Health and Research - COVID-19 Resources for Professionals

Development of effective immune response in adults with DS after Covid vaccine

The work shows the cellular and humoral responses to SARS-CoV-2 vaccination of 36 individuals with…

Rigsby RigsbyFebruary 7, 2022

Resources for Professionals

COVID-19 vaccination of individuals with Down syndrome – Data from the T21RS survey

The T21RS COVID-19 Initiative launched an international survey to obtain information on safety and efficacy…

Rigsby RigsbyJanuary 27, 2022

Health and Research - COVID-19

Information on COVID-19 Booster Shots from the Adult Down Syndrome Center

The physicians of the Adult Down Syndrome Center recommend that individuals with Down syndrome ages…

Rigsby RigsbyJanuary 18, 2022

Health and Research - COVID-19

COVID in DS, Omicron Edition

ID specialist and friend of the podcast, Dr. Andy Nowalk, joins the podcast to discuss…

Rigsby RigsbyJanuary 8, 2022

Health and Research - COVID-19

T21RS Press Release regarding COVID-19 Vaccine Safety in Individuals with Down Syndrome

Using new data from an ongoing survey of COVID-19 in people with Down syndrome aged…

Rigsby RigsbyDecember 9, 2021

Advisory on Long-COVID and Impact on Cognitive Function in Adults with Intellectual Disability

Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome

Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome

COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

Risk Prediction of COVID-19 Related Death and Hospital Admission in Adults after Vaccination

Development of effective immune response in adults with DS after Covid vaccine

COVID-19 vaccination of individuals with Down syndrome – Data from the T21RS survey

Information on COVID-19 Booster Shots from the Adult Down Syndrome Center

COVID in DS, Omicron Edition

T21RS Press Release regarding COVID-19 Vaccine Safety in Individuals with Down Syndrome

CONTACT LUMIND IDSC

QUICK LINKS

JOIN US